Devi, Gayathri R., & Finetti, Pascal, & Morse, Michael A., & Lee, Seayoung, & de Nonneville, Alexandre, & Van Laere, Steven, & Troy, Jesse, & Geradts, Joseph, & McCall, Shannon, & Bertucci, Francois. (June 2021).
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/10787
Devi, Gayathri R., and Finetti, Pascal, and Morse, Michael A., and Lee, Seayoung, and de Nonneville, Alexandre, and Van Laere, Steven, and Troy, Jesse, and Geradts, Joseph, and McCall, Shannon, and Bertucci, Francois.
"Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy". .
. (),
June 2021.
February 02, 2023.
http://hdl.handle.net/10342/10787.
Chicago:
Devi, Gayathri R. and Finetti, Pascal and Morse, Michael A. and Lee, Seayoung and de Nonneville, Alexandre and Van Laere, Steven and Troy, Jesse and Geradts, Joseph and McCall, Shannon and Bertucci, Francois,
"Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy," , no.
(June 2021),
http://hdl.handle.net/10342/10787 (accessed
February 02, 2023).
AMA:
Devi, Gayathri R., Finetti, Pascal, Morse, Michael A., Lee, Seayoung, de Nonneville, Alexandre, Van Laere, Steven, Troy, Jesse, Geradts, Joseph, McCall, Shannon, Bertucci, Francois.
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy. .
June 2021;
():
.
http://hdl.handle.net/10342/10787. Accessed
February 02, 2023.
